$CPRX 10-bagger corrected $1.25
Nasdaq GM
Website
$CPRX 10-bagger corrected $1.25
Nasdaq GM
Website
Shares Outstanding 82.87M
Float 56.73M
% Held by Insiders 16.60%
% Held by Institutions 53.90%
Shares Short 2.02M
Short Ratio 1.98
Short % of Float 2.62%
Shares Short (prior month) 1.8M
Headlines
and Filings
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as well as is in Phase II/III clinical trial for the treatment of MuSK-antibody positive myasthenia gravis. The company also develops CPP-115, a GABA aminotransferase inhibitor that is in Phase Ib clinical trial for the treatment of epilepsy and other neurological indications, such as complex partial seizures and Tourettes disorder; and CPP-109 to treat Tourettes disorder. It has a strategic collaboration with BioMarin Pharmaceutical Inc. for the development of Firdapse. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Surge in Revenue Growth Marks a Milestone for NOVOSENSE Give a pat on the back to NOVOSENSE (HKEX: 02676), because reporting a robust 66.73% bump in first-half revenue isn't small potatoes in today's tech landscape. This translates to around $374.54 million rolling into their coffers, which is quite a spectacle if you're watching the trend of sequential revenue growth...
Continue Reading
Timber Talk with Wes McAdams Diving into the nitty-gritty of building materials isn't everyone's cup of tea, but when you live in a place like Baton Rouge, understanding what stands up to the swampy summer heat is plain survival. The main focus? Cypress wood. Now, Wes McAdams from Cajun Cypress throws his hat into the ring, shedding some light on why cypress might just be...
Continue Reading
Call me a sucker for new tech but what Hohem just unveiled might flip content creation on its head. Welcome the Eyepic—a 2-in-1 pocket gimbal camera stirring things up at IFA 2026 in Berlin. Now, maybe your eyeballs are glazing over with all the camera announcements flooding the market. I get it. Yet, this gadget isn’t just another add-on; it's a sneaky move by Hohem...
Continue Reading
The java crowd is waking up to a new trend that's more than just a flash in the mug. We're looking at a market shift where the decaffeinated coffee scene is steaming ahead, geared up for a whopping $5.2 billion valuation by 2031, growing at a tidy 7% CAGR. Yeah, you read that right. So, what's brewing that's making this market percolate? Riding the Wave of...
Continue Reading
When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...
Continue Reading
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...
Continue Reading
Roborock's Strategic Leap at IFA 2026 Ah, Roborock—those smart folks who want to squeeze every second out of your day—even if it means they have to steam-blast your tile floor to free you up for something else. They've strutted their stuff at IFA 2026, and I'm not just talking robot vacuums clunking through living rooms. Nope. They're diving into pools now. What’s...
Continue Reading
AI Tech Takes Center Stage in Qingdao Kicking off the week, the 2026 China International Consumer Electronics Exposition unfolds its grand spectacle in Qingdao. Now, we're not just talking your average tech fare here—this is a heavyweight event with over 300 titans from 12 countries sprawling across a hefty 60,000 square meters. And those are numbers that make people...
Continue Reading
Passing the Baton in BRP's Financial Helm Alright, folks, grab your coffee and listen up. There's a shakeup coming from the cold corners of Valcourt, Quebec—BRP Inc., the powersports behemoth on the TSX: DOO, has announced a changing of the guard in their finance department. Come October 1st, there's a planned power shift as Sébastien Martel steps down as CFO, passing...
Continue Reading
Top 5 Most Recently Viewed Articles
This SentirJuntos review covers a platform that draws in users who want a structured way to meet people online rather than scroll through a photo feed hoping someone swipes back. SentirJuntos positions itself around conversation-first interaction — icebreakers, message threads, and member browsing — without the algorithmic matchmaking that defines many competitors....
Continue Reading
Understanding Novo Nordisk's Share Repurchase Program Novo Nordisk has embarked on an exciting journey by launching a share repurchase program, which reflects its ongoing commitment to enhancing value for shareholders. This initiative, recently introduced, adheres to European regulations aimed at safeguarding investors and upholding market integrity. Current Financial...
Continue Reading
Morgan Stanley's Impressive Q3 Earnings Performance Morgan Stanley has recently made headlines with its third-quarter earnings for 2024, which notably surpassed analysts’ predictions. This upbeat news has positively influenced the company’s stock performance, triggering a notable 2% rise in premarket trading. This increase can be attributed to the robust performance...
Continue Reading
Understanding the Growing Hair Removal Wax Market The global hair removal wax market is on the rise, projected to expand by USD 436.4 million within a few years. This transformation highlights the increasing popularity and benefits of hair removal wax products among consumers worldwide. The market's growth isn't just reflected in numbers; it's a shift towards beauty...
Continue Reading
Introduction to BioIVT and IDBS Collaboration In a significant step towards enhancing efficiencies in the biopharmaceutical sector, BioIVT, a leading provider of in vitro ADME research services, has collaborated with IDBS to implement the IDBS E-WorkBook platform. This initiative led to a remarkable reduction in study times by at least 30%, marking a transformative moment...
Continue Reading